October 21, 2011 — The European Medicines Agency agreed to a precautionary recall of Advagraf (tacrolimus; Astellas Pharma Canada) 0.5-mg capsule (yellow and orange) batches because of possible safety ...
Japan's Astellas Pharma has run into a new roadblock in its pursuit of regulatory approval of Advagraf, its second generation version of the blockbuster transplant drug Prograf. The FDA has raised ...
The European Medicines Agency has agreed to the immediate recall of some batches of 0.5 mg prolonged-release hard capsules of Advagraf (tacrolimus) from pharmacies and wholesalers across the European ...
Sustained use of Astellas’ immunosuppressant Advagraf offers a significant survival benefit in liver transplant patients, claims a new study published in the American Journal of Transplantation (AJT).
WASHINGTON Astellas says it has received a fourth approvable letter from the Food and Drug Administration for its immunosuppressant drug Advagraf, again delaying the drug’s approval. In December 2005, ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using PROGRAF or ADVAGRAF XL? PROGRAF or ADVAGRAF XL ...
European regulatory advisors have recommended approval of Teva Pharmaceutical’s generic version of Astellas’ transplant rejection treatment Advagraf. The Israeli generics manufacturer’s macrolide ...
The drug is formulated as prolonged-release hard capsules. The affected batches were distributed across the EU, with the greatest concentrations of remaining stock in the U.K. and Romania. The recall ...
Japanese drugmaker Astellas has launched its new immunosuppressant Advagraf in its first European markets - the UK and Germany - for patients undergoing organ transplantation. Japanese drugmaker ...
LONDON, April 30 /PRNewswire/ -- Astellas announced today that the European Commission has approved the immunosuppressant Advagraf(R) (generic name: tacrolimus, prolonged release) for prophylaxis of ...
Astellas Pharma India Private Limited has introduced the immunosuppressant drug Advagraf, also known as tacrolimus, a prolonged release capsule in India. The drug is a once-daily modified release ...
Astellas' hopes for a quick U.S. approval for Advagraf--a follow-up, new and improved version of the kidney transplant drug Prograf--have run into a serious obstacle. The drug company says that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results